Anthracycline Cardiotoxicity

QR Code

Anthracycline Cardiotoxicity

None

Saved in:

Bibliographic Details
Main Authors:	Visani, Giuseppe, Isidori, Alessandro, Minotti, Giorgio
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27290
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Natural strategies of preventing anthracycline-induced cardiotoxicity – a review
by: Anca STOICA, et al.
Published: (2022-12-01)

Anthracycline induced cardiotoxicity and differential gene expression in old mice
by: Weike Bao, et al.
Published: (2025-06-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01)

Roles of Non-Coding RNA in Anthracycline Cardiotoxicity: A Narrative Review
by: Xiao S, et al.
Published: (2025-07-01)

Trastuzumab and Cardiotoxicity
by: Fiuza, M., et al.
Published: (2012)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS
by: V. I. Chernov, et al.
Published: (2016-12-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Early Detection and Prediction of Cardiotoxicity - Biomarker and Echocardiographic Evaluation
by: Kinova, Elena, et al.
Published: (2012)

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity
by: Goukassian, David, et al.
Published: (2012)

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis
by: Ling Yin Fritz Wong, et al.
Published: (2025-07-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

Ejection Fraction Decline and Cardiotoxicity Following Anthracycline Chemotherapy: A Risk-Focused Study from an Indonesian Tertiary Care Center
by: Rizkyastari Onny, et al.
Published: (2025-06-01)

Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01)

Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukaemia
by: Piccaluga, Pier Paolo, et al.
Published: (2012)

Cell biobank as a necessary infrastructure for the development and implementation of mesenchymal stem cell-based therapy in the treatment of anthracycline-induced cardiotoxicity. Literature review and own data
by: L. Yu. Grivtsova, et al.
Published: (2020-12-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Ischemic stroke as the first manifestation of anthracycline cardiomyopathy
by: G. R. Ramazanov, et al.
Published: (2023-01-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

O2/CH4 Kinetic Mechanisms for Aerospace Applications at Low Pressure and Temperature, Validity Ranges and Comparison
by: Minotti, Angelo
Published: (2011)

Basic Research and Clinical Application of Drug Delivery Systems for the Treatment of Age-Related Macular Degeneration
by: Giudice, Giuseppe Lo, et al.
Published: (2012)

Mechanisms of the Cardiotoxic Action of Amitriptyline
by: G. V. Chekmarev, et al.
Published: (2011-12-01)

Course of arterial hypertension during breast cancer chemotherapy with anthracyclines
by: E. N. Berezikova, et al.
Published: (2024-10-01)

Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives
by: Rümeysa Yücer, et al.
Published: (2025-07-01)

CHANGE OF THE LEFT VENTRICLE FUNCTIONING IN LYMPHOMA TREATED WITH ANTHRACYCLINE ANTIBIOTICS
by: K. V. Shuykova, et al.
Published: (2016-01-01)

Anthracyclines and Acquired Long QT Syndrome. A Case Report
by: Carlos Rodríguez Armada, et al.
Published: (2014-12-01)

Forensic Investigation in Anaphylactic Deaths
by: Trani, Nicoletta, et al.
Published: (2011)

CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS
by: V. P. Volkov
Published: (2015-12-01)

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction
by: E. V. Grakova, et al.
Published: (2023-10-01)

Innovative Medical Devices for Telemedicine Applications
by: Giorgio, Agostino
Published: (2011)

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update
by: Vasvi Bhutani, et al.
Published: (2025-05-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
by: A. S. Zmitrukevich, et al.
Published: (2024-01-01)

RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS
by: N. T. Vatutin, et al.
Published: (2017-10-01)